Literature DB >> 3303305

Longitudinal study of group B streptococcal carriage during late pregnancy.

K Persson, B Bjerre, L Elfström, A Forsgren.   

Abstract

152 women were cultured for group B streptococci (GBS) weekly from the 37th week of gestation and at admission to hospital for delivery. Matched rectal, urethral and urine specimens were collected for study (mean 4 times). In the 37th week of gestation, 33 women (22%) harboured GBS in rectal specimens, 28 women (18%) in urethral specimens, 16 women (11%) in urine specimens, and 37 women (24%) in at least one of the 3 specimens. All cultures considered, a total of 46 women (30%) yielded GBS in at least one culture. In the 37th week of gestation, women subsequently found to be GBS colonized at labour (positive in at least one site) had a higher rate of positive cultures in rectal specimens (77%) than in either urethral (67%) or urine specimens (41%). Chronic GBS carriage was more frequent in rectum than in urethra or urine. The results of the present investigation support the gastrointestinal tract as being the predominant source of GBS.

Entities:  

Mesh:

Year:  1987        PMID: 3303305     DOI: 10.3109/00365548709018478

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Incidence of early onset group B streptococcal septicemia in Sweden 1973 to 1985.

Authors:  I Sjöberg; S Håkansson; A Eriksson; J Schollin; B Stjernstedt; I Tessin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

2.  Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.

Authors:  C Larsson; M Lindroth; P Nordin; M Stålhammar-Carlemalm; G Lindahl; I Krantz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

3.  Selective isolation of vancomycin-resistant enterococci.

Authors:  K G van Horn; C A Gedris; K M Rodney
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.